DFDA

Transsphenoidal Surgery

Treatment for Cushings Syndrome

Effectiveness
75%
Safety Score
65%
Clinical Trials
1
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
one-time procedure, lifelong follow-up
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$3,000
Side Effect Mgmt:$1,000
Total Annual:$5,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$70,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$6,667
Cost per Remission
$6,667
Transsphenoidal Surgery Outcomes

for Cushings Syndrome

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+75%
Remission Rate
+75%
Common Side Effects
Transient diabetes insipidus
+25%
Hypopituitarism (requiring replacement)
+15%
CSF leak
+3%
Hemorrhage/Infection
+0.5%

Sources:

researchgate.net
nih.gov
oup.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Transsphenoidal Surgery in Cushings Syndrome

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT

NCT06962202RECRUITING
View Study
100 participants
OBSERVATIONAL
Chandigarh, India
Started: Aug 15, 2022